Last10K.com

Marizyme Inc (MRZM) SEC Filing 8-K Material Event for the period ending Wednesday, January 5, 2022

Marizyme Inc

HISTORY TOOLS
CIK: 1830487 Ticker: MRZM

View differences made from one to another to evaluate Marizyme Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Marizyme Inc.

Continue

Assess how Marizyme Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Marizyme Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Cover

Material Contracts, Statements, Certifications & more

Marizyme Inc provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Additional Exhibits
Ticker: MRZM
CIK: 1413754
Form Type: 8-K Corporate News
Accession Number: 0001493152-22-000456
Submitted to the SEC: Wed Jan 05 2022 4:33:03 PM EST
Accepted by the SEC: Wed Jan 05 2022
Period: Wednesday, January 5, 2022
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/mrzm/0001493152-22-000456.htm